Columbus McKinnon Corporation — Form 10-Q Summary
Business context and reporting period
Columbus McKinnon designs, manufactures and markets material-handling products, systems and services, including hoists, rigging tools, actuators, digital power controls and crane solutions. The filing covers the three months ended June 30, 2019, the first quarter of fiscal 2020, with comparisons to the three months ended June 30, 2018. Approximately 55% of sales were generated in the United States and 45% internationally.
Key financial metrics
| Metric | Q1 FY2020 | Q1 FY2019 | Change |
|---|---|---|---|
| Net sales | $212.7 million | $225.0 million | Down 5.5% |
| Gross profit | $75.6 million | $79.6 million | Down 5.1% |
| Gross margin | 35.5% | 35.4% | Up 10 basis points |
| Income from operations | $27.0 million | $13.5 million | Up 100.3% |
| Operating margin | 12.7% | 6.0% | Improved |
| Net income | $18.6 million | $7.7 million | Up 141.1% |
| Diluted EPS | $0.78 | $0.33 | Up $0.45 |
| Cash flow from operations | $(2.2) million | $8.1 million | Declined |
Net sales reflected $11.1 million from businesses sold in fiscal 2019, a $5.1 million unfavorable foreign-currency effect, $3.8 million of pricing benefits and $0.1 million of volume growth. Product-group sales were $100.1 million for Crane Solutions, $92.0 million for Industrial Products and $20.6 million for Engineered Products.
Income tax expense was $5.2 million, representing a 22% effective rate versus 19% in the prior-year quarter. Cash, cash equivalents and restricted cash totaled $56.0 million at June 30, 2019, down $15.4 million from March 31, 2019. Working-capital usage, annual incentive payments and $6.2 million of U.S. pension contributions contributed to the operating cash outflow. Capital expenditures were $1.9 million.
Total debt consisted primarily of a $300.5 million term loan, including $65.0 million classified as current debt. The company repaid $10.0 million during the quarter and had no revolving borrowings, although $16.3 million of letters of credit were outstanding. Management planned to repay $65.0 million of term debt during the next 12 months. The company stated that cash, operating cash flows and available borrowing capacity should fund operations and capital expenditures for at least the next 12 months, subject to execution of its business plan and working-capital management.
Material changes versus the prior comparable period
- Revenue declined primarily because of divestitures and unfavorable currency translation, partly offset by pricing and modest volume growth.
- Gross margin was broadly stable despite unfavorable mix, tariffs, facility-closure costs and currency effects. Pricing net of material inflation and productivity actions provided offsets.
- Operating income and net income increased substantially because the prior-year quarter included an $11.1 million impairment loss related to businesses held for sale. The current quarter included only a $0.2 million final working-capital adjustment on those divestitures.
- Selling, general and administrative expenses and research and development expenses decreased, reflecting lower incentive and stock compensation, reduced integration costs and divested-business costs.
- Cash flow from operations changed from a $8.1 million inflow to a $2.2 million outflow, primarily due to working-capital movements, incentive payments and pension funding.
- The company adopted ASC 842 lease accounting on April 1, 2019, recognizing a $35.6 million operating lease right-of-use asset and corresponding liability. Management stated that the adoption did not materially affect operating results or cash flows.
Guidance, outlook, commentary, risks and unusual items
- Management expects fiscal 2020 capital expenditures of approximately $20 million, excluding acquisitions and strategic alliances.
- Management estimates a fiscal 2020 effective tax rate of approximately 22% to 23%.
- Trade tariffs were estimated to increase fiscal 2020 costs by approximately $3 million. The company is pursuing pricing and productivity actions to mitigate the impact.
- The company is executing its “Blueprint for Growth” strategy, emphasizing business simplification, operational excellence, new product development, digital platforms, margin expansion and improved return on invested capital.
- Management cited risks from global economic conditions, industrial demand, tariffs, steel and other raw-material costs, foreign currency, interest rates, competition, customer and supplier conditions, acquisitions and facility consolidations.
- Goodwill totaled $325.3 million and no impairment indicators were identified during the quarter. Future declines in projected revenue growth, margins or cash flows could result in impairment charges.
- Recorded contingencies included approximately $5.4 million for asbestos-related liabilities, $6.3 million for product-related liabilities and $0.9 million for known environmental matters. The company stated that pending litigation was not expected to have a material effect on financial condition or liquidity, although future charges could materially affect earnings.
- The company received $0.3 million of net asbestos-insurance settlement payments during the quarter. A July 2019 court ruling held that Travelers was obligated to defend Magnetek in litigation related to Monsanto claims, subject to possible appeal.
- The board declared a quarterly dividend of $0.06 per share on July 22, 2019, expected to total approximately $1.4 million.
Important facts for investors to verify
- Whether pricing and productivity initiatives offset the estimated $3 million tariff exposure and ongoing steel-cost pressures.
- The company’s ability to generate positive operating cash flow while pursuing planned $65 million debt repayment and funding approximately $20 million of fiscal 2020 capital expenditures.
- Revenue trends excluding divested businesses and the effects of foreign-currency translation.
- The sustainability of the improved operating margin after excluding the prior-year $11.1 million held-for-sale impairment.
- Progress and potential costs associated with asbestos, product-liability, environmental and Monsanto-related matters.
- Potential goodwill impairment if operating performance, forecasts, discount rates or market conditions deteriorate.
- Compliance with debt covenants and availability under the revolving facility, including the effect of outstanding letters of credit.